메뉴 건너뛰기




Volumn 18, Issue 17, 2012, Pages 2084-2091

Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats

Author keywords

Cirrhosis; Hepatic encephalopathy; Hyperammonemia; Insulin like growth factor 1; Low grade brain edema; Rifaximin

Indexed keywords

ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBON TETRACHLORIDE; ENDOTOXIN; GLUCOSE; GLUTAMINE; PLACEBO; RIFAXIMIN; SOMATOMEDIN C;

EID: 84860576212     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v18.i17.2084     Document Type: Article
Times cited : (14)

References (35)
  • 1
    • 0041669381 scopus 로고    scopus 로고
    • Pathogenesis of hepatic encephalopathy: New insights from neuroimaging and molecular studies
    • Butterworth RF. Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies. J Hepatol 2003; 39: 278-285
    • (2003) J Hepatol , vol.39 , pp. 278-285
    • Butterworth, R.F.1
  • 5
    • 0036829480 scopus 로고    scopus 로고
    • Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS
    • Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 2002; 36: 1163-1171
    • (2002) Hepatology , vol.36 , pp. 1163-1171
    • Olde Damink, S.W.1    Jalan, R.2    Redhead, D.N.3    Hayes, P.C.4    Deutz, N.E.5    Soeters, P.B.6
  • 8
    • 0036373262 scopus 로고    scopus 로고
    • Mechanisms of hyperammonemia
    • Bachmann C. Mechanisms of hyperammonemia. Clin Chem Lab Med 2002; 40: 653-662
    • (2002) Clin Chem Lab Med , vol.40 , pp. 653-662
    • Bachmann, C.1
  • 12
    • 0034030150 scopus 로고    scopus 로고
    • Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: A double-blind, randomized, dose-finding multi-centre study
    • Williams R, James OF, Warnes TW, Morgan MY. Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre study. Eur J Gastroenterol Hepatol 2000; 12: 203-208
    • (2000) Eur J Gastroenterol Hepatol , vol.12 , pp. 203-208
    • Williams, R.1    James, O.F.2    Warnes, T.W.3    Morgan, M.Y.4
  • 13
    • 0027212359 scopus 로고
    • Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy
    • Bucci L, Palmieri GC. Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy. Curr Med Res Opin 1993; 13: 109-118
    • (1993) Curr Med Res Opin , vol.13 , pp. 109-118
    • Bucci, L.1    Palmieri, G.C.2
  • 14
    • 75749116606 scopus 로고    scopus 로고
    • Review: Rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy
    • Alcorn J. Review: rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy. ACP J Club 2008; 149: 11
    • (2008) ACP J Club , vol.149 , pp. 11
    • Alcorn, J.1
  • 16
    • 0022826267 scopus 로고
    • In vitro and in vivo evaluation of L/105, a new topical intestinal rifamycin
    • Venturini AP, Marchi E. In vitro and in vivo evaluation of L/105, a new topical intestinal rifamycin. Chemioterapia 1986; 5: 257-262
    • (1986) Chemioterapia , vol.5 , pp. 257-262
    • Venturini, A.P.1    Marchi, E.2
  • 17
    • 0028041535 scopus 로고
    • Pharmacokinetic study of rifaximin after oral administration in healthy volunteers
    • Descombe JJ, Dubourg D, Picard M, Palazzini E. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers. Int J Clin Pharmacol Res 1994; 14: 51-56
    • (1994) Int J Clin Pharmacol Res , vol.14 , pp. 51-56
    • Descombe, J.J.1    Dubourg, D.2    Picard, M.3    Palazzini, E.4
  • 18
    • 0028958031 scopus 로고
    • Insulin-like growth factors and their binding proteins: Biological actions
    • Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34
    • (1995) Endocr Rev , vol.16 , pp. 3-34
    • Jones, J.I.1    Clemmons, D.R.2
  • 24
    • 77957138796 scopus 로고    scopus 로고
    • Rat CCl(4)-induced cirrhosis plus total portal vein ligation: A new model for the study of hyperammonaemia and brain oedema
    • Miquel M, Bartolí R, Odena G, Serafín A, Cabré E, Galan A, Barba I, Córdoba J, Planas R. Rat CCl(4)-induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema. Liver Int 2010; 30: 979-987
    • (2010) Liver Int , vol.30 , pp. 979-987
    • Miquel, M.1    Bartolí, R.2    Odena, G.3    Serafín, A.4    Cabré, E.5    Galan, A.6    Barba, I.7    Córdoba, J.8    Planas, R.9
  • 25
    • 0026027619 scopus 로고
    • A rodent model of cirrhosis, ascites, and bacterial peritonitis
    • Runyon BA, Sugano S, Kanel G, Mellencamp MA. A rodent model of cirrhosis, ascites, and bacterial peritonitis. Gastroenterology 1991; 100: 489-493
    • (1991) Gastroenterology , vol.100 , pp. 489-493
    • Runyon, B.A.1    Sugano, S.2    Kanel, G.3    Mellencamp, M.A.4
  • 26
    • 0002079850 scopus 로고
    • Animal models of portal hypertension
    • In: Okuda K, Benhamou JP. Portal hypertension. Tokyo: Springer-Verlag
    • Lebrec D. Animal models of portal hypertension. In: Okuda K, Benhamou JP. Portal hypertension. Clinical and Physiological aspects. Tokyo: Springer-Verlag, 1991: 101-113
    • (1991) Clinical and Physiological aspects , pp. 101-113
    • Lebrec, D.1
  • 27
    • 0030874289 scopus 로고    scopus 로고
    • Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
    • Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26: 1372-1378
    • (1997) J Hepatol , vol.26 , pp. 1372-1378
    • Guarner, C.1    Runyon, B.A.2    Young, S.3    Heck, M.4    Sheikh, M.Y.5
  • 28
    • 0031054156 scopus 로고    scopus 로고
    • The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy
    • Vogels BA, van Steynen B, Maas MA, Jörning GG, Chamuleau RA. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy. J Hepatol 1997; 26: 387-395
    • (1997) J Hepatol , vol.26 , pp. 387-395
    • Vogels, B.A.1    van Steynen, B.2    Maas, M.A.3    Jörning, G.G.4    Chamuleau, R.A.5
  • 29
    • 0026072529 scopus 로고
    • Classification of chronic viral hepatitis: A need for reassessment
    • Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-374
    • (1991) J Hepatol , vol.13 , pp. 372-374
    • Scheuer, P.J.1
  • 34
    • 0035201997 scopus 로고    scopus 로고
    • Effects of daily oral administration of rifaximin and neomycin on faecal aerobic flora in rats
    • Miglioli PA, Allerberger F, Calabrò GB, Gaion RM. Effects of daily oral administration of rifaximin and neomycin on faecal aerobic flora in rats. Pharmacol Res 2001; 44: 373-375
    • (2001) Pharmacol Res , vol.44 , pp. 373-375
    • Miglioli, P.A.1    Allerberger, F.2    Calabrò, G.B.3    Gaion, R.M.4
  • 35
    • 37249035165 scopus 로고    scopus 로고
    • Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS
    • Yang J, Lee HR, Low K, Chatterjee S, Pimentel M. Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci 2008; 53: 169-174
    • (2008) Dig Dis Sci , vol.53 , pp. 169-174
    • Yang, J.1    Lee, H.R.2    Low, K.3    Chatterjee, S.4    Pimentel, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.